patvann/followup-after-serotonergic-medication-initiation
patvann/followup-after-serotonergic-medication-initiation
Target Population
Designed for patients who have recently been prescribed a new medication from the SSRI (Selective Serotonin Reuptake Inhibitors) or SNRI (Serotonin-Norepinephrine Reuptake Inhibitors) classes with no prior history..
Recommendations
- Webhook Notification: When a new SSRI or SNRI prescription is made, a webhook is sent to the patient portal with information about these medications.
- Task Creation: A task is generated for the care coordination team to follow up with the patient in 2 weeks to assess medication tolerability.
- Follow-Up Appointment: A recommendation is made for the patient to schedule a follow-up visit in 4 weeks.
Importance
Ensures that patients starting on new SSRI or SNRI medications receive timely follow-up care. Crucial for monitoring how well the patients tolerate the medication and to address any potential side effects.
Conclusion
Integrates automated tasks and notifications into the patient management workflow. By generating follow-up tasks with direct patient notifications, enhancing care coordination and appropriate monitoring when starting a new SSRI or SNRI.
Resources
Serotonin Syndrome and Other Serotonergic Disorders
Serotonin syndrome is an iatrogenic disorder induced by pharmacologic treatment with serotonergic agents that increases serotonin activity. In addition, there is a wide variety of clinical disorders associated with serotonin excess. The frequent concurrent use of serotonergic and neuroleptic drugs and similarities between serotonin syndrome and neuroleptic malignant syndrome can present the clinician with a diagnostic challenge.
View Resource Paper